Back to Journals » Infection and Drug Resistance » Volume 12

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy

Total article views   HTML views PDF downloads Totals
9,336 Dovepress* 7,514+ 1,696 9,210
PubMed Central* 1,822 692 2,514
Totals 9,336 2,388 11,724
*Since 8 May 2019

View citations on PubMed Central and Google Scholar